... the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome ...  |  read more...

... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...  |  read more...

... the Starches and Starch Products market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers ...  |  read more...

... low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the ...  |  read more...

... increasingly aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, causing research and development to increase over the period. Firms in this industry primarily ...  |  read more...

... plans for a major research program to map the brain were revealed. Reports indicated that in next month’s budget, billions of dollars will be stipulated to embark on the so-called Brain Activity Map project. As ...  |  read more...

... Caribbean? What is the dollar value of these imports? How much do the imports of chromatographs and electrophoresis instruments vary from one country to another in North America & the Caribbean? Do exporters serving the ...  |  read more...

... - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others” provides key market data on the Mexico Dental Devices market. The report provides value (USD million), volume (units) ...  |  read more...

... as well as 5- and 10-year test volume forecasts by country and market segment. The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ...  |  read more...

... shifting funding sources have changed the type of research being performed. Historically, government money has been devoted mostly to basic research, meaning research without a specific goal. On the other hand, private and corporate money ...  |  read more...

... actively embracing technological innovation and cross-industry best practices as it continues its quest to regain long-term sustainability. Leading life science companies and their supporting vendor ecosystem are aligned as they both seek to move the ...  |  read more...

... Biotech/Janssen-Cilag). Further intensifying the future competitive landscape, two agents in late-stage trials for psoriasis offer the advantage of oral formulation: Pfizer’s Jak inhibitor tofacitinib and Celgene’s phosphodiesterase-4 (PDE-4) inhibitor apremilast.  Efficacious IL-17 inhibitors are also ...  |  read more...

... of 100 rheumatologists and 25 pharmacy directors at MCOs that offer both commercial health insurance and Medicare plans. PsA and SpA—which refers to a disease continuum including both undifferentiated (nonradiographic) axial SpA and ankylosing spondylitis ...  |  read more...